This is a combined synopsis/solicitation for commercial items for antiviral medication restock for the U. S. National Veterinary Stockpile. The solicitation is for Zanamivir relenza inhalation powder and Oseltamivir tamiflu oral antiviral capsules. It is a total small business set aside. Quotations are requested, and the award will be made to the offeror representing the best value to the government based on lowest price technically acceptable criteria, considering price and past performance. Delivery is required by September 24, 2026. Questions are due by July 15, 2026. Agency protests can be filed with the contracting officer or the USDA independent review authority.
The USDA requires delivery of all items by September 24, 2026. Early deliveries will be accepted. The usda requires delivery of all items by september 24, 2026. early deliveries will be accepted.
Award will be made to the offeror representing the best value to the government based on the lowest price technically acceptable criteria, considering price and past performance. he government will evaluate quotations based on the lowest price technically acceptable criteria. only the lowest priced offer will be evaluated for technical acceptability.
The acquisition is set aside for small business concerns. Offerors must be compliant with all applicable federal antidiscrimination laws and the equal protection principles of the U. S. Constitution. by submission of its offer, the offeror certifies that: 1 it is compliant with all applicable federal antidiscrimination laws and the equal protection principles of the u. s. constitution.
Questions are due no later than July 15, 2026, at 09:00 am eastern time. questions shall be submitted via email to ***@***. *. * and are due no later than july 15, 2026, at 09:00 am eastern time.
Submission of a knowing false statement relating to offerors compliance with DEI requirements may subject the offeror to liability under the false claims act or criminal liability. Failure to comply may be grounds for termination for default. submission of a knowing false statement relating to offerors compliance with the above requirements andor eligibility for the contract may subject the offeror to liability under the false claims act, 31 ****, andor criminal liability, including under 18 u. s. c. 287 and ****.